Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study.
Dudan ZhangXun TangPeng ShenYaqin SiXiaofei LiuZhe XuJinguo WuJingyi ZhangPing LuHongbo LinPei GaoPublished in: BMJ open (2019)
The prevalence of cardiometabolic multimorbidity in a general Chinese population increased more than doubled over 5 years, indicating rapid evolution of cardiometabolic multimorbidity. A history of CVD dominates the risk for mortality. A complementary strategy for primary and secondary prevention of cardiometabolic diseases is needed in China.